558 related articles for article (PubMed ID: 19026743)
1. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
Zhao WQ; Townsend M
Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
3. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
[TBL] [Abstract][Full Text] [Related]
4. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
5. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
6. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
8. The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease.
Desai GS; Zheng C; Geetha T; Mathews ST; White BD; Huggins KW; Zizza CA; Broderick TL; Babu JR
J Alzheimers Dis; 2014; 42(2):347-56. PubMed ID: 24858405
[TBL] [Abstract][Full Text] [Related]
9. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
Chung JY; Kim HS; Song J
Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.
Verdile G; Keane KN; Cruzat VF; Medic S; Sabale M; Rowles J; Wijesekara N; Martins RN; Fraser PE; Newsholme P
Mediators Inflamm; 2015; 2015():105828. PubMed ID: 26693205
[TBL] [Abstract][Full Text] [Related]
11. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
de la Monte SM
Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal Molecular Interactions between the Aβ Peptide Linked to Alzheimer's Disease and Insulin Linked to Diabetes Mellitus Type II.
Luo J; Wärmländer SK; Gräslund A; Abrahams JP
ACS Chem Neurosci; 2016 Mar; 7(3):269-74. PubMed ID: 26785771
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
Kimura N
Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
[TBL] [Abstract][Full Text] [Related]
14. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
[TBL] [Abstract][Full Text] [Related]
15. Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review.
Berlanga-Acosta J; Guillén-Nieto G; Rodríguez-Rodríguez N; Bringas-Vega ML; García-Del-Barco-Herrera D; Berlanga-Saez JO; García-Ojalvo A; Valdés-Sosa MJ; Valdés-Sosa PA
Front Endocrinol (Lausanne); 2020; 11():560375. PubMed ID: 33224105
[TBL] [Abstract][Full Text] [Related]
16. Biological mechanisms linking Alzheimer's disease and type-2 diabetes mellitus.
Mushtaq G; Khan JA; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(7):1192-201. PubMed ID: 25230227
[TBL] [Abstract][Full Text] [Related]
17. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.
Rad SK; Arya A; Karimian H; Madhavan P; Rizwan F; Koshy S; Prabhu G
Drug Des Devel Ther; 2018; 12():3999-4021. PubMed ID: 30538427
[TBL] [Abstract][Full Text] [Related]
18. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
19. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Stanley M; Macauley SL; Holtzman DM
J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of β-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model.
Lin F; Jia J; Qin W
Neuroreport; 2014 Nov; 25(16):1289-95. PubMed ID: 25202927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
